Article by Mike Okada, Cannabis Life Network
Health Canada is requiring warning labels and patient information handouts for opioids, marking a first for these kinds of medicine, which puts the pharmaceutical painkillers in a similar league as tobacco, alcohol, and cannabis. In addition, pharmaceutical companies will have to develop mandatory opioid risk management plans as well.
This development is a positive step forward because at least governments are beginning to recognize the key role that pharmaceutical painkillers have played in the opioid crisis, and while the effectiveness of these health warnings can be debated- just look at the ones for alcohol or tobacco- opioid producers should be held accountable.
The requirement does not go into effect until October and will comprise of a warning sticker slapped onto the pill bottle before it’s given to the patient.
Cannabis gets a stop sign while opioids get a yellow yield sign?
So wait, let’s get this straight. Cannabis, a relatively benign drug with a plethora of medical and recreational uses gets a red stop sign warning label, while opioids, which killed over 122,000 people globally in 2015, gets a yellow yield sign?
Given the continuing anti-cannabis, prohibitionist hysteria, that sounds about right.